| Dr Michael J Unruh, MD | |
|
330 E Beltline Ave Ne, Suite 100, Grand Rapids, MI 49506-1267 | |
| (616) 752-6235 | |
| (616) 752-6324 |
| Full Name | Dr Michael J Unruh |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 20 Years |
| Location | 330 E Beltline Ave Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104036532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 4301097953 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - Greenville Dialysis | Greenville, MI | Dialysis facility |
| Davita - Ionia Dialysis | Ionia, MI | Dialysis facility |
| Fmc Clyde Park - Wyoming | Wyoming, MI | Dialysis facility |
| Davita - Beltline Home Training | Grand rapids, MI | Dialysis facility |
| Spectrum Health | Grand rapids, MI | Hospital |
| Mercy Health Saint Mary's | Grand rapids, MI | Hospital |
| Metro Health Hospital | Wyoming, MI | Hospital |
| Spectrum Health United Hospital | Greenville, MI | Hospital |
| Spectrum Health Pennock | Hastings, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renal Associates Of West Michigan Pc | 2466348644 | 19 |
| Rawm Vascular Access Pllc | 3072832625 | 3 |
News Archive
On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.
Benefitfocus today announced the acquisition of BeliefNetworks, Inc., a leader in transforming real-time data – including consumer behavior, marketing campaign data and social networking conversations – into actionable knowledge for customers. The agreement includes three patent applications and proprietary software code. These assets and the highly-experienced staff of BeliefNetworks are a valuable addition to Benefitfocus, the leader in Software as a Service solutions for health and voluntary benefits.
Across the U.S., governors are contemplating ways to ease the fiscal pressure Medicaid has placed on their state budgets. The approaches currently on the table include freezing the enrollment of childless adults, transforming Medicaid into a block grant program and convincing Congress to give states more flexibility to administer the program.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
› Verified 4 days ago
| Entity Name | Renal Associates Of West Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871674200 PECOS PAC ID: 2466348644 Enrollment ID: O20040225000277 |
News Archive
On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.
Benefitfocus today announced the acquisition of BeliefNetworks, Inc., a leader in transforming real-time data – including consumer behavior, marketing campaign data and social networking conversations – into actionable knowledge for customers. The agreement includes three patent applications and proprietary software code. These assets and the highly-experienced staff of BeliefNetworks are a valuable addition to Benefitfocus, the leader in Software as a Service solutions for health and voluntary benefits.
Across the U.S., governors are contemplating ways to ease the fiscal pressure Medicaid has placed on their state budgets. The approaches currently on the table include freezing the enrollment of childless adults, transforming Medicaid into a block grant program and convincing Congress to give states more flexibility to administer the program.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
› Verified 4 days ago
| Entity Name | Rawm Vascular Access Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710378377 PECOS PAC ID: 3072832625 Enrollment ID: O20150501001112 |
News Archive
On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.
Benefitfocus today announced the acquisition of BeliefNetworks, Inc., a leader in transforming real-time data – including consumer behavior, marketing campaign data and social networking conversations – into actionable knowledge for customers. The agreement includes three patent applications and proprietary software code. These assets and the highly-experienced staff of BeliefNetworks are a valuable addition to Benefitfocus, the leader in Software as a Service solutions for health and voluntary benefits.
Across the U.S., governors are contemplating ways to ease the fiscal pressure Medicaid has placed on their state budgets. The approaches currently on the table include freezing the enrollment of childless adults, transforming Medicaid into a block grant program and convincing Congress to give states more flexibility to administer the program.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael J Unruh, MD 330 E Beltline Ave Ne, Suite 100, Grand Rapids, MI 49506-1267 Ph: (616) 752-6235 | Dr Michael J Unruh, MD 330 E Beltline Ave Ne, Suite 100, Grand Rapids, MI 49506-1267 Ph: (616) 752-6235 |
News Archive
On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.
Benefitfocus today announced the acquisition of BeliefNetworks, Inc., a leader in transforming real-time data – including consumer behavior, marketing campaign data and social networking conversations – into actionable knowledge for customers. The agreement includes three patent applications and proprietary software code. These assets and the highly-experienced staff of BeliefNetworks are a valuable addition to Benefitfocus, the leader in Software as a Service solutions for health and voluntary benefits.
Across the U.S., governors are contemplating ways to ease the fiscal pressure Medicaid has placed on their state budgets. The approaches currently on the table include freezing the enrollment of childless adults, transforming Medicaid into a block grant program and convincing Congress to give states more flexibility to administer the program.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
› Verified 4 days ago
Maureen U Tan- Pedres, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Suite A721, Grand Rapids, MI 49503 Phone: 616-391-3139 Fax: 616-391-3044 | |
Jeffery Allen Woo, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1900 Wealthy St Se, Ste 150, Grand Rapids, MI 49506 Phone: 616-459-3158 Fax: 616-988-0071 | |
Robert W Selfe, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne, Suite 200, Grand Rapids, MI 49503 Phone: 616-267-8950 Fax: 616-267-8585 | |
Dr. Erin Megan Pettijohn, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 250 Cherry St Se Ste 2200, Grand Rapids, MI 49503 Phone: 616-685-5600 | |
Dr. Andrew Leo Sochacki, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5800 Foremost Dr Se Ste 200, Grand Rapids, MI 49546 Phone: 616-389-1800 | |
Stephanie F Williams, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 5200, Grand Rapids, MI 49503 Phone: 616-486-5933 Fax: 616-486-6489 | |
Simin Beg, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 145 Michigan St Ne Ste 3410, Grand Rapids, MI 49503 Phone: 616-391-9945 |